Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5. J Infect. 2021. PMID: 33549625 Free PMC article.
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.
Mora D, Mateo J, Nieto JA, Bikdeli B, Yamashita Y, Barco S, Jimenez D, Demelo-Rodriguez P, Rosa V, Yoo HHB, Sadeghipour P, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica (RIETE) Investigators. Mora D, et al. Br J Haematol. 2023 Jun;201(5):971-981. doi: 10.1111/bjh.18737. Epub 2023 Mar 21. Br J Haematol. 2023. PMID: 36942630
Imatinib might constitute a treatment option for lung involvement in COVID-19.
Bernal-Bello D, Jaenes-Barrios B, Morales-Ortega A, Ruiz-Giardin JM, García-Bermúdez V, Frutos-Pérez B, Farfán-Sedano AI, de Ancos-Aracil C, Bermejo F, García-Gil M, Zapatero-Gaviria A, San Martín-López JV. Bernal-Bello D, et al. Autoimmun Rev. 2020 Jul;19(7):102565. doi: 10.1016/j.autrev.2020.102565. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376403 Free PMC article. No abstract available.
Imatinib for COVID-19: A case report.
Morales-Ortega A, Bernal-Bello D, Llarena-Barroso C, Frutos-Pérez B, Duarte-Millán MÁ, García de Viedma-García V, Farfán-Sedano AI, Canalejo-Castrillero E, Ruiz-Giardín JM, Ruiz-Ruiz J, San Martín-López JV. Morales-Ortega A, et al. Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27. Clin Immunol. 2020. PMID: 32599278 Free PMC article. No abstract available.
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.08.034. Epub 2021 Aug 23. J Infect. 2022. PMID: 34437930 Free PMC article. No abstract available.
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.
Duarte-Millán MA, Mesa-Plaza N, Guerrero-Santillán M, Morales-Ortega A, Bernal-Bello D, Farfán-Sedano AI, García de Viedma-García V, Velázquez-Ríos L, Frutos-Pérez B, De Ancos-Aracil CL, Soria Fernández-Llamazares G, Toledano-Macías M, Cristóbal-Bilbao R, Luquín-Ciuro N, Marrero-Francés J, Piedrabuena-García SI, Satué-Bartolomé JA, Gonzalo-Pascua S, Rivilla-Jiménez M, Carpintero-García L, Ayala-Larrañaga I, García-Bermúdez V, Lara-Montes C, Llerena-Riofrío ÁR, RIvas-Prado L, Walter S, Escriba-Barcena A, San Martín López JV, Ruíz-Giardín JM. Duarte-Millán MA, et al. J Med Virol. 2022 Apr;94(4):1540-1549. doi: 10.1002/jmv.27488. Epub 2021 Dec 7. J Med Virol. 2022. PMID: 34845754 Free PMC article.
29 results